Lung Stent Market: Rising Prevalence of Lung Cancer and Respiratory Diseases
The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market. The lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. The market is segmented based on the type, material, product, end user, and region. Based on the type, the tracheobronchial segment accounted for the largest share of the airway stent/lung stent market in 2018. The large share of this segment can be attributed to the higher adoption trends seen in the tracheal and bronchial stents for use in the treatments of respiratory disorders . Based on material, the airway stent/lung stent market is divided into...